Abstract
Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Current Proteomics
Title: Systems Biology: Understanding Function from Genes to Networks
Volume: 6 Issue: 2
Author(s): Ravinder Singh and Rob Knight
Affiliation:
Abstract: Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Export Options
About this article
Cite this article as:
Singh Ravinder and Knight Rob, Systems Biology: Understanding Function from Genes to Networks, Current Proteomics 2009; 6 (2) . https://dx.doi.org/10.2174/157016409788680974
DOI https://dx.doi.org/10.2174/157016409788680974 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) <i>In-Silico</i> Validation and Fabrication of Matrix Diffusion-Based Polymeric Transdermal Patches for Repurposing Gabapentin Hydrochloride in Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Physicochemical Characterization of Nano- and Microparticles
Current Nanoscience Quinoline as a Privileged Scaffold in Cancer Drug Discovery
Current Medicinal Chemistry Investigation on the Effects of Antimicrobial imidazo[2,1-b]thiazole Derivatives on the Genitourinary Microflora
Medicinal Chemistry Heat Shock Proteins in Diabetes and Wound Healing
Current Protein & Peptide Science Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine Engineered Gold Nanoshells Killing Tumor Cells: New Perspectives
Current Pharmaceutical Design Role of Ischemic Blood-Brain Barrier on Amyloid Plaques Development in Alzheimers Disease Brain
Current Neurovascular Research Mitochondria, Cellular Stress Resistance, Somatic Cell Depletion and Lifespan
Current Aging Science Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology Bioinformatic Analysis of HIV-1 Entry and Pathogenesis
Current HIV Research Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies Inhibitors of Myostatin- and Proteasome-Dependent Signaling for Attenuating Muscle Wasting
Recent Patents on Regenerative Medicine An Overview on Keratinocyte Growth Factor: From the Molecular Properties to Clinical Applications
Protein & Peptide Letters From Nanotechnology to Nanomedicine: Applications to Cancer Research
Current Molecular Medicine Copper (II) – HisAibGly Complex and Its Superoxide Dismutase Activity (Suplementary Material)
Protein & Peptide Letters Expression of Angiogenesis-related Genes in a Group of Iranian Cases of Breast Cancer
Current Pharmacogenomics and Personalized Medicine Teaching Pharmacogenetics in Low and Middle-Income Countries: Team Based Learning and Lessons Learned at the American University of Beirut
Current Pharmacogenomics and Personalized Medicine